Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models

References

• Abraham, M. J., & Gready, J. E. (2011). Optimization of parameters for molecular dynamics simulation using smooth particle-mesh Ewald in GROMACS 4.5. Journal of Computational Chemistry, 32(9), 2031–2040.
   PubMed Web of Science ®Google Scholar
• Banks, J. L., Beard, H. S., Cao, Y., Cho, A. E., Damm, W., Farid, R., … Levy, R. M. (2005). Integrated modeling program, applied chemical theory (IMPACT). Journal of Computational Chemistry, 26(16), 1752–1780.
   PubMed Web of Science ®Google Scholar
• Bas, D. C., Rogers, D. M., & Jensen, J. H. (2008). Very fast prediction and rationalization of pKa values for protein-ligand complexes. Proteins, 73(3), 765–783.
   PubMed Web of Science ®Google Scholar
• Bashford, D., & Case, D. A. (2000). Generalized born models of macromolecular solvation effects. Annual Review of Physical Chemistry, 51, 129–152.
   PubMed Web of Science ®Google Scholar
• Berendsen, H. J. C., Vanderspoel, D., & Vandrunen, R. (1995). Gromacs – A message-passing parallel molecular-dynamics implementation. Computer Physics Communications, 91(1–3), 43–56.
   Web of Science ®Google Scholar
• Berg, T. (2003). Modulation of protein-protein interactions with small organic molecules. Angewandte Chemie-International Edition, 42(22), 2462–2481.
   PubMed Web of Science ®Google Scholar
• Berg, T. (2006). Inhibition of TNF-alpha signaling: divide and conquer. ChemMedChem, 1(7), 687–688.
   PubMed Web of Science ®Google Scholar
• Best, R. B., Zhu, X., Shim, J., Lopes, P. E., Mittal, J., Feig, M., & Mackerell, A. D., Jr. (2012). Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone phi, psi and side-chain chi(1) and chi(2) dihedral angles. Journal of Chemical Theory Computation, 8(9), 3257–3273.
   PubMed Web of Science ®Google Scholar
• Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., … Cerretti, D. P. (1997). A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature, 385(6618), 729–733.
   PubMed Web of Science ®Google Scholar
• Brenner, D., Blaser, H., & Mak, T. W. (2015). Regulation of tumour necrosis factor signalling: Live or let die. Nature Reviews Immunology, 15(6), 362–374.
   PubMed Web of Science ®Google Scholar
• Brzustewicz, E., & Bryl, E. (2015). The role of cytokines in the pathogenesis of rheumatoid arthritis – Practical and potential application of cytokines as biomarkers and targets of personalized therapy. Cytokine, 76(2), 527–536.
   PubMed Web of Science ®Google Scholar
• Buchwald, P. (2010). Small-molecule protein-protein interaction inhibitors: Therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations. Iubmb Life, 62(10), 724–731.
   PubMed Web of Science ®Google Scholar
• Case, D. A. (2002). Generalized born models of macromolecular solvation effects. Abstracts of Papers of the American Chemical Society, 223, C47–C47.
   Web of Science ®Google Scholar
• Chan, D. S., Lee, H. M., Yang, F., Che, C. M., Wong, C. C., Abagyan, R., … Ma, D. L. (2010). Structure-based discovery of natural-product-like TNF-α inhibitors. Angewandte Chemie International Edition English, 49(16), 2860–2864.
   PubMed Web of Science ®Google Scholar
• Chatzantoni, K., & Mouzaki, A. (2006). Anti-TNF-alpha antibody therapies in autoimmune diseases. Current Topics in Medicinal Chemistry, 6(16), 1707–1714.
   PubMed Web of Science ®Google Scholar
• Chen, S., Feng, Z., Wang, Y., Ma, S., Hu, Z., Yang, P., … Xie, X. (2017). Discovery of novel ligands for TNF-alpha and TNF receptor-1 through structure-based virtual screening and biological assay. Journal of Chemical Informative Model, 57(5), 1101–1111.
   PubMed Web of Science ®Google Scholar
• Clackson, T. (2006). Breaking and entering. Natural Chemistry Biology, 2(1), 14–15.
   PubMed Web of Science ®Google Scholar
• C.P., A., Subhramanian, S., Sizochenko, N., Melge, A.R., Leszczynski, J., & Mohan, C.G. (2018) Multiple e-Pharmacophore modeling to identify a single molecule that could target both streptomycin and paromomycin binding sites for 30S ribosomal subunit inhibition. Journal of Biomolecular Structure Dynamics, 7, 1–15. doi: 10.1080/07391102.2018.1462731
   Web of Science ®Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle Mesh Ewald – An N.Log(N) method for Ewald sums in large systems. Journal of Chemical Physics, 98(12), 10089–10092.
   Web of Science ®Google Scholar
• Davis, J. M., & Colangelo, J. (2013). Small-molecule inhibitors of the interaction between TNF and TNFR. Future Medicinal Chemistry, 5(1), 69–79.
   PubMed Web of Science ®Google Scholar
• Deepu, K. P., Thomas, B., & Harindran, J. (2016) Design, synthesis and evaluation of specific TNF-α inhibitory novel dithioic acid derivative from natural acids as anti-inflammatory agents. International Journal of Pharmateutical Chemistry, 6, 42–44
   Google Scholar
• Dixon, S. L., Smondyrev, A. M., Knoll, E. H., Rao, S. N., Shaw, D. E., & Friesner, R. A. (2006). PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. Journal of Computational Aided Molecular Design, 20(10–11), 647–671.
   PubMed Web of Science ®Google Scholar
• Douni, E., & Kollias, G. (1998). A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin alpha, or the p55TNF-R. Journal of Experimental Medicine, 188(7), 1343–1352.
   PubMed Web of Science ®Google Scholar
• Ekhteiari Salmas, R., Unlu, A., Bektaş, M., Yurtsever, M., Mestanoglu, M., & Durdagi, S. (2017) Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: Combination of in silico and in vitro studies. Journal of Biomolecular Structure & Dynamics, 35(9), 1899–1915.
   PubMed Web of Science ®Google Scholar
• Elliott, M. J., Maini, R. N., Feldmann, M., Longfox, A., Charles, P., Katsikis, P., … Woody, J. N. (1993). Treatment of rheumatoid-arthritis with chimeric monoclonal-antibodies to tumor-necrosis-factor-alpha. Arthritis and Rheumatism, 36(12), 1681–1690.
   PubMed Web of Science ®Google Scholar
• Ertl, P., Roggo, S., & Schuffenhauer, A. (2008). Natural product-likeness score and its application for prioritization of compound libraries. Journal of Chemical Informative Model, 48(1), 68–74.
   PubMed Web of Science ®Google Scholar
• Evans, D. J., & Holian, B. L. (1985). The Nose-Hoover thermostat. Journal of Chemical Physics, 83(8), 4069–4074.
   Web of Science ®Google Scholar
• Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., … Shenkin, P. S. (2004). Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medical Chemistry, 47(7), 1739–1749.
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., … Mainz, D. T. (2006). Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medical Chemistry, 49(21), 6177–6196.
   PubMed Web of Science ®Google Scholar
• Grell, M., Douni, E., Wajant, H., Lohden, M., Clauss, M., Maxeiner, B., … Scheurich, P. (1995). The transmembrane form of tumor-necrosis-factor is the prime activating ligand of the 80 Kda tumor-necrosis-factor receptor. Cell, 83(5), 793–802.
   PubMed Web of Science ®Google Scholar
• Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004). Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. Journal of Medical Chemistry, 47(7), 1750–1759.
   PubMed Web of Science ®Google Scholar
• Haraguchi, S., Day, N. K., Kamchaisatian, W., Beigier-Pompadre, M., Stenger, S., Tangsinmankong, N., … Cianciolo, G. J. (2006). LMP-420, a small-molecule inhibitor of TNF-alpha, reduces replication of HIV-1 and Mycobacterium tuberculosis in human cells. AIDS Research Therapy, 3, 8.
   PubMedGoogle Scholar
• He, M. M., Smith, A. S., Oslob, J. D., Flanagan, W. M., Braisted, A. C., Whitty, A., … Cunningham, B. C. (2005). Small-molecule inhibition of TNF-alpha. Science, 310(5750), 1022–1025.
   PubMed Web of Science ®Google Scholar
• Horiuchi, T., Mitoma, H., Harashima, S., Tsukamoto, H., & Shimoda, T. (2010). Transmembrane TNF-alpha: Structure, function and interaction with anti-TNF agents. Rheumatology (Oxford) , 49(7), 1215–1228.
   PubMed Web of Science ®Google Scholar
• Huang, J., & MacKerell, A. D., Jr. (2013). CHARMM36 all-atom additive protein force field: Validation based on comparison to NMR data. Journal of Computational Chemistry, 34(25), 2135–2145.
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphical Model, 14(1), 33–38.
   Web of Science ®Google Scholar
• Jana, S., & Singh, S. K. (in press). Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches. Journal of Biomolecular Structure &Dynamics, doi: 10.1080/07391102.2018.1444510
   Web of Science ®Google Scholar
• Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991). Transgenic mice expressing human tumor-necrosis-factor – A predictive genetic model of arthritis. EMBO Journal, 10(13), 4025–4031.
   PubMed Web of Science ®Google Scholar
• Kollias, G., & Kontoyiannis, D. (2002). Role of TNF/TNFR in autoimmunity: Specific TNF receptor blockade may be advantageous to anti-TNF treatments. Cytokine & Growth Factor Reviews, 13(4–5), 315–321.
   PubMed Web of Science ®Google Scholar
• Kontermann, R. E., Scheurich, P., & Pfizenmaier, M. (2009). Antagonists of TNF action: Clinical experience and new developments. Expert Opinion on Drug Discovery, 4(3), 279–292.
   PubMed Web of Science ®Google Scholar
• Lee, J., Cheng, X., Swails, J. M., Yeom, M. S., Eastman, P. K., Lemkul, J. A., … Im, W. (2016). CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field. Journal of Chemical Theory Computation, 12(1), 405–413.
   PubMed Web of Science ®Google Scholar
• Lee, M. R., & Dominguez, C. (2005). MAP kinase p38 inhibitors: Clinical results and an intimate look at their interactions with p38alpha protein. Current Medical Chemistry, 12(25), 2979–2994.
   PubMed Web of Science ®Google Scholar
• Li, H., Robertson, A. D., & Jensen, J. H. (2005). Very fast empirical prediction and rationalization of protein pKa values. Proteins, 61(4), 704–721.
   PubMed Web of Science ®Google Scholar
• Li, J., Abel, R., Zhu, K., Cao, Y., Zhao, S., & Friesner, R. A. (2011). The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling. Proteins, 79(10), 2794–2812.
   PubMed Web of Science ®Google Scholar
• Mateen, S., Zafar, A., Moin, S., Khan, A. Q., & Zubair, S. (2016). Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis. Clinical Chimica Acta, 455, 161–171.
   PubMed Web of Science ®Google Scholar
• McInnes, I. B., & Schett, G. (2011). Mechanisms of disease the pathogenesis of rheumatoid arthritis. New England Journal of Medicine, 365(23), 2205–2219.
   PubMed Web of Science ®Google Scholar
• Melagraki, G., Ntougkos, E., Rinotas, V., Papaneophytou, C., Leonis, G., Mavromoustakos, T., … Kollias, G. (2017). Cheminformatics-aided discovery of small-molecule protein-protein interaction (PPI) dual inhibitors of tumor necrosis factor (TNF) and receptor activator of NF-kappaB Ligand (RANKL). PLoS Computational Biology, 13(4), e1005372.
   PubMed Web of Science ®Google Scholar
• MetaCoreTM, MetaCore/MetaDrug version 6.31, Clarivate Analytics (2018)
   Google Scholar
• Newman, D. J., & Cragg, G. M. (2007). Natural products as sources of new drugs over the last 25 years. Journal of Natural Products, 70(3), 461–477.
   PubMed Web of Science ®Google Scholar
• Palladino, M. A., Bahjat, F. R., Theodorakis, E. A., & Moldawer, L. L. (2003). Anti-TNF-alpha therapies: The next generation. Nature Reviews Drug Discovery, 2(9), 736–746.
   PubMed Web of Science ®Google Scholar
• Rasmussen, H. S., & McCann, P. P. (1997). Matrix metalloproteinase inhibition as a novel anticancer strategy: A review with special focus on batimastat and marimastat. Pharmacological Therapy, 75(1), 69–75.
   PubMed Web of Science ®Google Scholar
• Sansom, M. S. P., Tieleman, D. P., Forrest, L. R., & Berendsen, H. J. C. (1998). Molecular dynamics simulations of membranes with embedded proteins and peptides: Porin, alamethicin and influenza virus M2. Biochemical Society Transactions, 26(3), 438–443.
   PubMed Web of Science ®Google Scholar
• Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013). Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. Journal of Computational Aided Molecular Design, 27(3), 221–234.
   PubMed Web of Science ®Google Scholar
• Schrodinger LLC (2014), Maestro Molecular Modeling Package, New York.
   Google Scholar
• Schrodinger LLC (2014), Maestro Molecular Modeling Package, Prime Module, New York.
   Google Scholar
• Sfikakis, P. P. (2010). The first decade of biologic TNF antagonists in clinical practice: Lessons learned, unresolved issues and future directions. Currents Directions in Autoimmunity, 11, 180–210.
   PubMedGoogle Scholar
• Shelley, J. C., Cholleti, A., Frye, L. L., Greenwood, J. R., Timlin, M. R., & Uchimaya, M. (2007). Epik: A software program for pK(a) prediction and protonation state generation for drug-like molecules. Journal of Computational Aided Molecular Design, 21(12), 681–691.
   PubMed Web of Science ®Google Scholar
• Siu, S. W., Pluhackova, K., & Bockmann, R. A. (2012). Optimization of the OPLS-AA force field for long hydrocarbons. Journal of Chemical Theory Computation, 8(4), 1459–1470.
   PubMed Web of Science ®Google Scholar
• Verdonk, M. L., Cole, J. C., Hartshorn, M. J., Murray, C. W., & Taylor, R. D. (2003). Improved protein-ligand docking using GOLD. Proteins, 52(4), 609–623.
   PubMed Web of Science ®Google Scholar
• Wajant, H., Pfizenmaier, K., & Scheurich, P. (2003). Tumor necrosis factor signaling. Cell Death Differ, 10, 45–65.
   PubMed Web of Science ®Google Scholar
• Zaka, M., Sehgal, S. A., Shafique, S., & Abbasi, B. H. (2017). Comparative in silico analyses of Cannabis sativa, Prunella vulgaris and Withania somnifera compounds elucidating the medicinal properties against rheumatoid arthritis. Journal of Molecular Graphical Model, 74, 296–304.
   PubMed Web of Science ®Google Scholar